NCT04529044 177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer Status RECRUITING Phase PHASE2
NCT03872778 [177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake Status COMPLETED Phase PHASE1/PHASE2